Jonathan Quick
Corporate Officer/Principal bij LOGICBIO THERAPEUTICS, INC.
Actieve functies van Jonathan Quick
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
| Comptroller/Controller/Auditor | 31-12-2020 | 11-01-2021 | |
| Director of Finance/CFO | 01-04-2019 | - |
Loopbaan van Jonathan Quick
Eerdere bekende functies van Jonathan Quick
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | - | - |
| CELLDEX THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Opleiding van Jonathan Quick
| Providence College | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Corporate Officer/Principal | 3 |
| Comptroller/Controller/Auditor | 1 |
| Director of Finance/CFO | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
| Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CELLDEX THERAPEUTICS, INC. | Health Services |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
- Beurs
- Insiders
- Jonathan Quick
- Ervaring
